NCT07287982 · Interventional trial
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Overall registry status Recruiting
Phase 2
Conditions Spinal Muscular Atrophy (SMA)
Delaware Valley sites
- Children's Hospital Philadelphia - Neurology · Philadelphia, PA · Philadelphia County · Not yet recruiting
First posted
Registry updated
Added to the directory